mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for TIMM44
Gene summary
Basic gene Info.Gene symbolTIMM44
Gene nametranslocase of inner mitochondrial membrane 44 homolog (yeast)
SynonymsTIM44
CytomapUCSC genome browser: 19p13.2
Type of geneprotein-coding
RefGenesNM_006351.3,
Descriptionmitochondrial import inner membrane translocase subunit TIM44mitochondrial inner membrane translocase
Modification date20141207
dbXrefs MIM : 605058
HGNC : HGNC
Ensembl : ENSG00000104980
HPRD : 05450
Vega : OTTHUMG00000182478
ProteinUniProt: O43615
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_TIMM44
BioGPS: 10469
PathwayNCI Pathway Interaction Database: TIMM44
KEGG: TIMM44
REACTOME: TIMM44
Pathway Commons: TIMM44
ContextiHOP: TIMM44
ligand binding site mutation search in PubMed: TIMM44
UCL Cancer Institute: TIMM44
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for TIMM44

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
M419R418WBRCA1
M419R418LKIRC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for TIMM44
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
M419R418W-0.71086281
M419R418L-0.45712597
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for TIMM44 from PDB

Top
Differential gene expression and gene-gene network for TIMM44
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of TIMM44 and the right PPI network was created from samples without mutations in the LBS of TIMM44. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for TIMM44
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for TIMM44
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of TIMM44 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
1PEPENTAETHYLENE GLYCOL2cw9AM419


Top
Conservation information for LBS of TIMM44
Multiple alignments for O43615 in multiple species
LBSAA sequence# speciesSpecies
A445LLDISASSTEQ3Homo sapiens, Mus musculus, Rattus norvegicus
A445LLEVHMQETPL1Caenorhabditis elegans
A445ILEFVRGGSRQ1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
A445IVDFARARAVD1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
M331NILEAMISGEL2Mus musculus, Rattus norvegicus
M331NVLEAMISGEL1Homo sapiens
M331NILEAFIRFDL1Caenorhabditis elegans
M331EILEAYVKGDV1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
M331EVTEAYVKGDK1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
M399QAQLVMVVRNP1Homo sapiens
M399QVYMINVTKNA1Caenorhabditis elegans
M399QAQVVMVIKNS1Mus musculus
M399QAQLVMVIKNP1Rattus norvegicus
M399RAQEINLYRKK1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
M399RTQEVHMFKDA1Schizosaccharomyces pombe (strain 972 / ATCC 24843)
M419DKVLRMLYVWA2Homo sapiens, Rattus norvegicus
M419DNPKRINHIWV1Caenorhabditis elegans
M419DKVQRMLYVWA1Mus musculus
M419ANILMSSYAMV1Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
M419DRIQQCTYASV1Schizosaccharomyces pombe (strain 972 / ATCC 24843)


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas